Healthcare

Microbiome Technologies Energizing Pharma and Life Sciences

A New World of Microbiome Innovations

INDUSTRY
Healthcare

RELEASE DATE
28-Jun-2017
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D7B3-01-00-00-00
SKU
HC02836-GL-TR_20310
Yes
SHARE

Microbiome Technologies Energizing Pharma and Life Sciences
Published on: 28-Jun-2017 | SKU: HC02836-GL-TR_20310

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witness across the microbiome industry parallels, the growth that took place across genomics. Some of the milestones that have occurred in the microbiome field are the application of next generation screening towards identifying and assessing microbial levels within the human gut. Using these microbial biomarkers, scientists are pushing the boundaries by identifying novel drug targets as well as probiotic or prebiotic products that could aid in balancing the microbial ecosystem within the human body.

1.1 Key Findings

1.2 Interest Across The “Microbiome” Rapidly Rising

1.3 The Past, Present & Future of Human Microbiomics

1.4 Microbiome Product Diversity And Segmentation

2.1 Technology Overview: Therapeutics

2.2 Technology Overview: Over-the-counter

2.3 Technology Overview: Diagnostic Products & Services

3.1 More than 50% of all Microbiome Research is Focused Towards the GI

3.2 Multiple Diseases Have Unmet Therapeutics Needs

3.3 Clostridium difficile Threat Increasing due to Increasing Antibiotic use

3.4 Inflammatory Bowel Disease Another Large Unmet Area of Urgent Need

3.5 Skin Disorders Have Found A New Age Therapeutic Solution

3.6 Lifestyle Disorders Could Also Be Controlled Through the Microbiome

3.7 Immune-Microbiome A New Avenue In Cancer Research

3.8 OTC Microbiome Products Have Numerous Consumer Target Segments

3.9 OTC Microbiome Products Promote A Balanced Micro-ecosystem

3.10 Documented Usage of Probiotics Across Human Health is Diverse

4.1 Largest Contribution Towards the Microbiome Product Landscape Comes from Probiotic Drugs

4.2 Microbiome Therapeutics are Developed to with a Strategic Technical Design Based Approach

4.3 OTC Microbiome Products – Key Segments

4.4 OTC Microbiome Products – Some Probiotics/Prebiotic Stakeholders

4.5 Current Microbiome Company Ecosystem Segmented by Technology Focus

4.6 Microbiome Stakeholders Mergers, Acquisitions & Partnerships Snapshot

5.1 Approach–Company Profile

5.2 Seres Health (Seres Therapeutics)

5.3 AvidBiotics

5.4 Rebiotix

5.5 Ritter Pharmaceutical

5.6 Vedanta Biosciences

5.7 C3 Jian

6.1 Regional Analysis of OTC Health Innovations

6.2 Regional Analysis of Diagnostic/Services Innovations

6.3 Technology Roadmap

7.1 Growth Opportunity 7: Microbiome

7.2 Major Growth Opportunities for Microbiome

7.3 Strategic Imperatives for Microbiome Technology Stakeholders

Legal Disclaimer

8.1 The Frost & Sullivan Story

8.2 Value Proposition: Future of Your Company & Career

8.3 Global Perspective

8.4 Industry Convergence

8.5 360º Research Perspective

8.6 Implementation Excellence

8.7 Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

26 Oct 2026   |   Global   |   Technology Research

Game-Changing Innovations Transforming Cardiovascular Care

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.